Paper317254
Multicentre trials of praziquantel in human schistosomiasis: design and techniques.
Davis A and 1 other. Bull World Health Organ, 1979. Cited by 83 papers, by iCite.
Cite this record
ConductScience Library. Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Papers, record 317254. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/317254
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Clinical Trials as Topic | Major topic |
| Isoquinolines | Major topic |
| Praziquantel | Major topic |
| Schistosomiasis | Major topic |
| Double-Blind Method | |
| Female | |
| Humans | |
| Male | |
| World Health Organization |
Source PubMed
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 410178 | Praziquantel, a new board-spectrum antischistosomal agent. | Z Parasitenkd | 1977 | https://conductscience.org/library/papers/410178 | PubMed |
| 2 | 396055 | Double-blind studies of tolerance to praziquantel in Japanese patients with Schistosoma japonicum infections. | Bull World Health Organ | 1979 | https://conductscience.org/library/papers/396055 | PubMed |
| 3 | 334117 | Mutagenicity studies with praziquantel, a new anthelmintic drug: tissue-, host-, and urine-mediated mutagenicity assays. | Arch Toxicol | 1977 | https://conductscience.org/library/papers/334117 | PubMed |
| 4 | 580366 | Mutagenicity studies with praziquantel, a new anthelmintic drug, in mammalian systems. | Arch Toxicol | 1978 | https://conductscience.org/library/papers/580366 | PubMed |
| 5 | 926185 | Carcinogenic effects of niridazole on rodents infected with Schistosoma mansoni. | J Natl Cancer Inst | 1977 | https://conductscience.org/library/papers/926185 | PubMed |
| 6 | 906624 | A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei im hamsters. | Z Parasitenkd | 1977 | https://conductscience.org/library/papers/906624 | PubMed |
| 7 | 906623 | The efficacy of praziquantel against cestodes in animals. | Z Parasitenkd | 1977 | https://conductscience.org/library/papers/906623 | PubMed |
| 8 | 1235062 | Carcinogenic effects of niridazole. | Cancer Lett | 1975 | https://conductscience.org/library/papers/1235062 | PubMed |
| 9 | 180276 | Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni. | J Pharmacol Exp Ther | 1976 | https://conductscience.org/library/papers/180276 | PubMed |
| 10 | 4413726 | Hycanthone analogs: dissociation of mutagenic effects from antischistosomal effects. | Science | 1974 | https://conductscience.org/library/papers/4413726 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 83 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36278582 | Swiss-Chinese Cooperation in Tropical Medicine: The Role of Professor Marcel Tanner. | Diseases | 2022 | https://conductscience.org/library/papers/36278582 | PubMed |
| 35448830 | Schistosomiasis at the Crossroad to Elimination: Review of Eclipsed Research with Emphasis on the Post-Transmission Agenda. | Trop Med Infect Dis | 2022 | https://conductscience.org/library/papers/35448830 | PubMed |
| 33508096 | The history of the neglected tropical disease movement. | Trans R Soc Trop Med Hyg | 2021 | https://conductscience.org/library/papers/33508096 | PubMed |
| 33116680 | Genetic Diversity of Schistosoma haematobium in Qena Governorate, Upper Egypt. | Infect Drug Resist | 2020 | https://conductscience.org/library/papers/33116680 | PubMed |
| 32730343 | Cloning and functional complementation of ten Schistosoma mansoni phosphodiesterases expressed in the mammalian host stages. | PLoS Negl Trop Dis | 2020 | https://conductscience.org/library/papers/32730343 | PubMed |
| 32400351 | Schistosomiasis Consortium for Operational Research and Evaluation: Mission Accomplished. | Am J Trop Med Hyg | 2020 | https://conductscience.org/library/papers/32400351 | PubMed |
| 32106428 | Current and Novel Therapies Against Helminthic Infections: The Potential of Antioxidants Combined with Drugs. | Biomolecules | 2020 | https://conductscience.org/library/papers/32106428 | PubMed |
| 31060317 | Schistosomiasis Elimination: Beginning of the End or a Continued March on a Trodden Path. | Trop Med Infect Dis | 2019 | https://conductscience.org/library/papers/31060317 | PubMed |
| 30736431 | Elimination of Schistosomiasis Mekongi from Endemic Areas in Cambodia and the Lao People's Democratic Republic: Current Status and Plans. | Trop Med Infect Dis | 2019 | https://conductscience.org/library/papers/30736431 | PubMed |
| 30572592 | Artemether and Praziquantel: Origin, Mode of Action, Impact, and Suggested Application for Effective Control of Human Schistosomiasis. | Trop Med Infect Dis | 2018 | https://conductscience.org/library/papers/30572592 | PubMed |
| 28793922 | Comparison of novel and standard diagnostic tools for the detection of Schistosoma mekongi infection in Lao People's Democratic Republic and Cambodia. | Infect Dis Poverty | 2017 | https://conductscience.org/library/papers/28793922 | PubMed |
| 28351414 | Controlling schistosomiasis with praziquantel: How much longer without a viable alternative? | Infect Dis Poverty | 2017 | https://conductscience.org/library/papers/28351414 | PubMed |
| 26174621 | Can human schistosomiasis mansoni control be sustained in high-risk transmission foci in Egypt? | Parasit Vectors | 2015 | https://conductscience.org/library/papers/26174621 | PubMed |
| 25099517 | Drugs for treating urinary schistosomiasis. | Cochrane Database Syst Rev | 2014 | https://conductscience.org/library/papers/25099517 | PubMed |
| 12709312 | Combination chemotherapy of schistosomiasis in laboratory studies and clinical trials. | Antimicrob Agents Chemother | 2003 | https://conductscience.org/library/papers/12709312 | PubMed |
| 11076716 | Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. | Emerg Infect Dis | 2000 | https://conductscience.org/library/papers/11076716 | PubMed |
| 7222647 | Schistosomiasis: recent developments in immunology and treatment. | West J Med | 1980 | https://conductscience.org/library/papers/7222647 | PubMed |
| 6973414 | The schistosomiasis problem in the world: results of a WHO questionnaire survey. | Bull World Health Organ | 1981 | https://conductscience.org/library/papers/6973414 | PubMed |
| 6794779 | The six diseases of WHO. Schistosomiasis: some advances. | Br Med J (Clin Res Ed) | 1981 | https://conductscience.org/library/papers/6794779 | PubMed |
| 3551827 | Clinical study evaluating efficacy of praziquantel in clonorchiasis. | Antimicrob Agents Chemother | 1987 | https://conductscience.org/library/papers/3551827 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/317254
GET https://conductscience.org/api/papers/v1/317254/cited_by?page=2